253 related articles for article (PubMed ID: 9391062)
1. Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo[a,l]pyrene or its diol epoxides.
Melendez-Colon VJ; Smith CA; Seidel A; Luch A; Platt KL; Baird WM
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13542-7. PubMed ID: 9391062
[TBL] [Abstract][Full Text] [Related]
2. Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures.
Melendez-Colon VJ; Luch A; Seidel A; Baird WM
Chem Res Toxicol; 2000 Jan; 13(1):10-7. PubMed ID: 10649961
[TBL] [Abstract][Full Text] [Related]
3. A novel method for the isolation and identification of stable DNA adducts formed by Dibenzo[a,l]pyrene and Dibenzo[a,l]pyrene 11, 12-dihydrodiol 13,14-epoxides in vitro.
Devanesan P; Ariese F; Jankowiak R; Small GJ; Rogan EG; Cavalieri EL
Chem Res Toxicol; 1999 Sep; 12(9):796-801. PubMed ID: 10490500
[TBL] [Abstract][Full Text] [Related]
4. Identification and quantification of the depurinating DNA adducts formed in mouse skin treated with dibenzo[a,l]pyrene (DB[a,l]P) or its metabolites and in rat mammary gland treated with DB[a,l]P.
Cavalieri EL; Rogan EG; Li KM; Todorovic R; Ariese F; Jankowiak R; Grubor N; Small GJ
Chem Res Toxicol; 2005 Jun; 18(6):976-83. PubMed ID: 15962932
[TBL] [Abstract][Full Text] [Related]
5. Identification and quantification of stable DNA adducts formed from dibenzo[a,l]pyrene or its metabolites in vitro and in mouse skin and rat mammary gland.
Todorovic R; Devanesan P; Rogan E; Cavalieri E
Chem Res Toxicol; 2005 Jun; 18(6):984-90. PubMed ID: 15962933
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cytochrome P450- and peroxidase-dependent metabolic activation of the potent carcinogen dibenzo[a,l]pyrene in human cell lines: formation of stable DNA adducts and absence of a detectable increase in apurinic sites.
Melendez-Colon VJ; Luch A; Seidel A; Baird WM
Cancer Res; 1999 Apr; 59(7):1412-6. PubMed ID: 10197604
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the morphological transforming activities of dibenzo[a,l]pyrene and benzo[a]pyrene in C3H10T1/2CL8 cells and characterization of the dibenzo[a,l]pyrene-DNA adducts.
Nesnow S; Davis C; Nelson G; Ross JA; Allison J; Adams L; King LC
Carcinogenesis; 1997 Oct; 18(10):1973-8. PubMed ID: 9364008
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective activation of dibenzo[a,l]pyrene and its trans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay.
Ralston SL; Coffing SL; Seidel A; Luch A; Platt KL; Baird WM
Chem Res Toxicol; 1997 Jun; 10(6):687-93. PubMed ID: 9208176
[TBL] [Abstract][Full Text] [Related]
9. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
[TBL] [Abstract][Full Text] [Related]
10. DNA damage, repair, and mutation induction by (+)-Syn and (-)-anti-dibenzo[a,l]pyrene-11,12-diol-13,14-epoxides in mouse cells.
Yoon JH; Besaratinia A; Feng Z; Tang MS; Amin S; Luch A; Pfeifer GP
Cancer Res; 2004 Oct; 64(20):7321-8. PubMed ID: 15492252
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective activation of dibenzo[a,l]pyrene to (-)-anti (11R,12S,13S,14R)- and (+)-syn(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7.
Ralston SL; Seidel A; Luch A; Platt KL; Baird WM
Carcinogenesis; 1995 Dec; 16(12):2899-907. PubMed ID: 8603462
[TBL] [Abstract][Full Text] [Related]
12. Identification and quantification of DNA adducts in the oral tissues of mice treated with the environmental carcinogen dibenzo[a,l]pyrene by HPLC-MS/MS.
Zhang SM; Chen KM; Aliaga C; Sun YW; Lin JM; Sharma AK; Amin S; El-Bayoumy K
Chem Res Toxicol; 2011 Aug; 24(8):1297-303. PubMed ID: 21736370
[TBL] [Abstract][Full Text] [Related]
13. Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites.
Melendez-Colon VJ; Luch A; Seidel A; Baird WM
Carcinogenesis; 1999 Oct; 20(10):1885-91. PubMed ID: 10506100
[TBL] [Abstract][Full Text] [Related]
14. Preparation, isolation, and characterization of Dibenzo[a,l]pyrene diol epoxide-deoxyribonucleoside monophosphate adducts by HPLC and fluorescence line-narrowing spectroscopy.
Devanesan P; Ariese F; Jankowiak R; Small GJ; Rogan EG; Cavalieri EL
Chem Res Toxicol; 1999 Sep; 12(9):789-95. PubMed ID: 10490499
[TBL] [Abstract][Full Text] [Related]
15. The potent carcinogen dibenzo[a,l]pyrene is metabolically activated to fjord-region 11,12-diol 13,14-epoxides in human mammary carcinoma MCF-7 cell cultures.
Ralston SL; Lau HH; Seidel A; Luch A; Platt KL; Baird WM
Cancer Res; 1994 Feb; 54(4):887-90. PubMed ID: 8313376
[TBL] [Abstract][Full Text] [Related]
16. Identification and quantitation of dibenzo[a,l]pyrene--DNA adducts formed by rat liver microsomes in vitro: preponderance of depurinating adducts.
Li KM; Todorovic R; Rogan EG; Cavalieri EL; Ariese F; Suh M; Jankowiak R; Small GJ
Biochemistry; 1995 Jun; 34(25):8043-9. PubMed ID: 7794917
[TBL] [Abstract][Full Text] [Related]
17. The level of DNA modification by (+)-syn-(11S,12R,13S,14R)- and (-)-anti-(11R,12S,13S,14R)-dihydrodiol epoxides of dibenzo[a,l]pyrene determined the effect on the proteins p53 and p21WAF1 in the human mammary carcinoma cell line MCF-7.
Luch A; Kudla K; Seidel A; Doehmer J; Greim H; Baird WM
Carcinogenesis; 1999 May; 20(5):859-65. PubMed ID: 10334204
[TBL] [Abstract][Full Text] [Related]
18. Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene.
Luch A; Coffing SL; Tang YM; Schneider A; Soballa V; Greim H; Jefcoate CR; Seidel A; Greenlee WF; Baird WM; Doehmer J
Chem Res Toxicol; 1998 Jun; 11(6):686-95. PubMed ID: 9625737
[TBL] [Abstract][Full Text] [Related]
19. Spectral and conformational analysis of deoxyadenosine adducts derived from syn- and anti-Dibenzo[a,l]pyrene diol epoxides: fluorescence studies.
Jankowiak R; Lin CH; Zamzow D; Roberts KP; Li KM; Small GJ
Chem Res Toxicol; 1999 Sep; 12(9):768-77. PubMed ID: 10490497
[TBL] [Abstract][Full Text] [Related]
20. The K-region trans-8,9-diol does not significantly contribute as an intermediate in the metabolic activation of dibenzo[a,l]pyrene to DNA-binding metabolites by human cytochrome P450 1A1 or 1B1.
Luch A; Kishiyama S; Seidel A; Doehmer J; Greim H; Baird WM
Cancer Res; 1999 Sep; 59(18):4603-9. PubMed ID: 10493514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
